Optionele productanalyse
Met uw toestemming gebruiken we privacyvriendelijke, beperkte analyses om te begrijpen welke onderzoeksroutes werken. We gebruiken geen advertentietrackers of sessieopnamen. U kunt deze keuze wijzigen in Voorkeuren. Lees het Privacybeleid.
Norwegian Cruise Line Holdings Ltd.'s published Hold conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $6.9B | |
|---|---|---|
| Revenue (ttm) | 10.2B | |
| Net income (ttm) | 760.8M | |
| EPS (ttm) | $1.59 | |
| Shares out | 459.2M | |
| P/E (trailing) | 10.2x | |
| P/E (forward) | 8.5x | |
| Volume | 16,399,018 | |
| Beta | 1.96 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $648.0M | $4.84B | $8.55B | $9.48B | $9.83B | +97.3% |
| Gross profit | $-960.1M | $576.7M | $3.08B | $3.79B | $3.14B | — |
| Operating income | $-2.55B | $-1.55B | $930.9M | $1.47B | $1.56B | — |
| Net income | $-4.51B | $-2.27B | $166.2M | $910.3M | $423.2M | — |
| EPS (diluted) | $-12.33 | $-5.41 | $0.39 | $1.89 | $0.92 | — |
| EBITDA | $-1.67B | $-665.1M | $1.77B | $2.49B | $3.82B | — |
| R&D | — | — | — | — | — | — |
| SG&A | $891.5M | $1.38B | $1.34B | $1.43B | $1.55B | +14.8% |
Recent company headlines from major financial publishers.
The base case represents the modal expectation where near-term yield headwinds in Europe are managed through cost discipline ($225M savings), and free cash flow inflects positively as newbuild capex declines. Deleveraging progresses methodically, supporting our Fair Value midpoint of $14.86.
Under favorable macroeconomic conditions, commercial initiatives at Norwegian brand rebuild top-of-funnel bookings, eliminating promotional discounting. Oceania and Regent brands maintain premium pricing power. Accelerated cash flow generation enables rapid debt extinguishment, lowering the equity risk premium and driving the valuation toward the upper band.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 10.6% | $15.7 | $15.9 | $16.1 | $16.3 | $16.5 |
| 11.1% | $15.1 | $15.3 | $15.5 | $15.6 | $15.8 |
| 11.6% | $14.6 | $14.7 | $14.9 | $15.0 | $15.2 |
| 12.1% | $14.1 | $14.2 | $14.3 | $14.5 | $14.6 |
| 12.6% | $13.6 | $13.7 | $13.8 | $14.0 | $14.1 |
Upcoming earnings date and setup when available.
De rating die de gepubliceerde researcheditie van elke maand droeg. Een rating vergelijkt de koers op de analysedatum met de fair value; het is geen overzicht van of de inschatting juist bleek.
| Jaar | jan | feb | mrt | apr | mei | jun | jul | aug | sep | okt | nov | dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |